“Today’s report from the HHS Inspector General makes it clear that list price increases on brand drugs are hurting patients,” said David Mitchell, founder of the advocacy group Patients for Affordable Drugs.

from Kaiser Health News https://ift.tt/2LpcvkD

0 comments:

Post a Comment

Popular Posts